Print
Print
NQF

Quality Positioning System (QPS)

Measure Description Display Information

0380: Hematology: Multiple Myeloma: Treatment with Bisphosphonates
0380
Hematology: Multiple Myeloma: Treatment with Bisphosphonates
STEWARD: American Society of Hematology
Measure Description:
Percentage of patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission, who were prescribed or received intravenous bisphosphonate therapy within the 12 month reporting period
Numerator Statement:
Patients who were prescribed or received intravenous bisphosphonate therapy within the 12 month reporting period
Denominator Statement:
All patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission
Exclusions:
For Claims/Registry:
Documentation of medical reason(s) for not prescribing bisphosphonates (eg, patients who do not have bone disease, patients with dental disease, patients with renal insufficiency)

Documentation of patient reason(s) for not prescribing bisphosphonates
Risk Adjustment:
No risk adjustment or risk stratification
Classification:
Measure Type:
Process
Measure Format:
measure
Condition:
Cancer, Hematologic
Non-Condition Specific:
Care Setting:
Outpatient Services
National Quality Strategy Priorities:
Effective Communication and Care Coordination
Current Use:
Planned Use:
Payment Program, Professional Certification or Recognition Program, Public reporting, Quality Improvement (internal to the specific organization), Quality Improvement with Benchmarking (external benchmarking to multiple organizations)
Data Source:
Claims, Registry Data
Level of Analysis:
Clinician: Group/Practice, Clinician: Individual
Target Population:
Elderly
Measure Selection Attributes (Learn more):
Measure Steward Contact Information:
For additional measure specification information, please contact the Measure Steward.
Measure Steward Organization:
American Society of Hematology
Primary Measure Steward Contact:


Measure Disclaimer:
2
0
Status
Most Recent Activity:
Measure Retired and Endorsement Removed Cancer Fall Cycle 2017
Initial Endorsement:
Jul 31, 2008
Last Endorsement Date:
Aug 09, 2012
Next Planned Maintenance Review:
N/A
Corresponding Measures:
Not Available
View Specifications:
Measure History:
Measure(s) Considered in Harmonization Request
${HarmonizationAssositeMeasures}
0
NQF Disclaimer: Measures may be used for non-commercial implementation and/or reporting of performance data. Contact the Measure Steward if you wish to use the measure for another purpose. NQF is not responsible for the application or outcomes of measures.